| 30 Sep 2014 |
ESMO 2014 Press Release: Cancer Medicine Becoming Ever More Precise, Practice-Changing Results at ESMO 2014 Show |
|
| 29 Sep 2014 |
ESMO 2014 Press Commentary: Anti-PD-L1 Antibody Shows Promising Activity in Advanced Bladder Cancer after Decades of Silence |
Genitourinary cancers -
Cancer Immunology and Immunotherapy |
| 29 Sep 2014 |
ESMO 2014 Press Release: PIK3CA Mutations Blunt Benefit of Anti-HER2 Drugs |
Breast cancer -
Translational research -
Anticancer agents & Biologic therapy |
| 29 Sep 2014 |
ESMO 2014 Press Release: RAS Testing Only the First Step for Choosing Treatment for Metastatic Colorectal Cancer, Important New Data Show |
Gastrointestinal cancers |
| 29 Sep 2014 |
ESMO 2014 Press Release: Promising Results Shown with Targeted Approaches in Subsets of Non-Small-Cell Lung Cancer |
Lung and other thoracic tumours -
Anticancer agents & Biologic therapy |
| 29 Sep 2014 |
ESMO 2014 Press Release: Nivolumab Shows Signs of Superior Response Rate Compared to Standard Chemotherapy in Advanced Melanoma |
Melanoma and other skin tumours -
Cancer Immunology and Immunotherapy |
| 29 Sep 2014 |
ESMO 2014 Press Release: Studies Report New Findings on Treatment Options for Mesothelioma |
Lung and other thoracic tumours -
Cancer Immunology and Immunotherapy -
Anticancer agents & Biologic therapy |
| 29 Sep 2014 |
ESMO 2014 Press Release: New Data on Combination Treatments for Melanoma |
Melanoma and other skin tumours -
Anticancer agents & Biologic therapy |
| 28 Sep 2014 |
ESMO 2014 Press Commentary: CLEOPATRA Trial Changes Standard Therapy for Metastatic HER2 Positive Breast Cancer |
Breast cancer -
Anticancer agents & Biologic therapy |
| 28 Sep 2014 |
ESMO 2014 Press Release: Treatments for Advanced Cancer Less Available in Eastern Europe, Reveals ESMO Survey |
Bioethics, legal and economic issues |
| 28 Sep 2014 |
ESMO 2014 Press Release: MAGRIT Phase III Trial Results Raise Questions About the Future of Lung Cancer Vaccination |
Lung and other thoracic tumours -
Cancer Immunology and Immunotherapy |
| 28 Sep 2014 |
ESMO 2014 Press Release: Significant Presence of Women in Oncology, but Still Under-Representation in Leadership Positions, Greek Survey Shows |
Bioethics, legal and economic issues |
| 28 Sep 2014 |
ESMO 2014 Press Release: Many Patients Lack Information About the Use of Targeted Therapies, Oncologists Say |
Bioethics, legal and economic issues |
| 28 Sep 2014 |
ESMO 2014 Press Release: Adding Cediranib to Chemotherapy Improves Progression-Free Survival for Metastatic or Recurrent Cervical Cancer, Phase II Trial Shows |
Gynaecologic malignancies -
Anticancer agents & Biologic therapy |
| 28 Sep 2014 |
ESMO 2014 Press Release: Pertuzumab Adds 16 Months Survival Benefit to Trastuzumab and Chemotherapy Treatment for HER2-Positive Metastatic Breast Cancer |
Breast cancer -
Anticancer agents & Biologic therapy |
